S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
Fisker Inc. (NYSE: FSR) Stock is an Overlooked U.S. EV Play
pixel
Marvell Technology (NASDAQ:MRVL) Stock a Buy: An Underrated Semi Company
Desktop Metal (NYSE: DM) Stock is a Next-Gen 3D Printing Buy
In duel with small investors over GameStop, big funds blink
Stocks have their worst day since October as Big Tech sinks
AP sources: Biden to pause oil and gas sales on public lands
In battle over GameStop shares, two big players flinch
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
Fisker Inc. (NYSE: FSR) Stock is an Overlooked U.S. EV Play
pixel
Marvell Technology (NASDAQ:MRVL) Stock a Buy: An Underrated Semi Company
Desktop Metal (NYSE: DM) Stock is a Next-Gen 3D Printing Buy
In duel with small investors over GameStop, big funds blink
Stocks have their worst day since October as Big Tech sinks
AP sources: Biden to pause oil and gas sales on public lands
In battle over GameStop shares, two big players flinch
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
Fisker Inc. (NYSE: FSR) Stock is an Overlooked U.S. EV Play
pixel
Marvell Technology (NASDAQ:MRVL) Stock a Buy: An Underrated Semi Company
Desktop Metal (NYSE: DM) Stock is a Next-Gen 3D Printing Buy
In duel with small investors over GameStop, big funds blink
Stocks have their worst day since October as Big Tech sinks
AP sources: Biden to pause oil and gas sales on public lands
In battle over GameStop shares, two big players flinch
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
Fisker Inc. (NYSE: FSR) Stock is an Overlooked U.S. EV Play
pixel
Marvell Technology (NASDAQ:MRVL) Stock a Buy: An Underrated Semi Company
Desktop Metal (NYSE: DM) Stock is a Next-Gen 3D Printing Buy
In duel with small investors over GameStop, big funds blink
Stocks have their worst day since October as Big Tech sinks
AP sources: Biden to pause oil and gas sales on public lands
In battle over GameStop shares, two big players flinch
Log in
CVE:RVV

Revive Therapeutics Stock Forecast, Price & News

C$0.08
+0.01 (+14.29 %)
(As of 07/22/2019)
Add
Compare
Today's Range
C$0.08
Now: C$0.08▼
C$0.09
50-Day Range
C$0.08
MA: C$0.08▼
C$0.08
52-Week Range
C$0.07
Now: C$0.08▼
C$0.25
Volume212,852 shs
Average Volume93,085 shs
Market CapitalizationC$5.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.

MarketRank™

Overall MarketRank™

0.50 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange CVE
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolCVE:RVV
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.revivethera.com
Phone+1-905-6055535
EmployeesN/A
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current Ratio6.14
Quick Ratio6.03

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowC$0.03 per share
Price / Cash Flow3.18
Book ValueC$0.02 per share
Price / Book4.21

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares72,411,000
Market CapC$5.79 million
Next Earnings Date2/26/2021 (Estimated)
OptionableNot Optionable
C$0.08
+0.01 (+14.29 %)
(As of 07/22/2019)
30 days | 90 days | 365 days | Advanced Chart

Receive RVV News and Ratings via Email

Sign-up to receive the latest news and ratings for RVV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Revive Therapeutics (CVE:RVV) Frequently Asked Questions

What stocks does MarketBeat like better than Revive Therapeutics?

Wall Street analysts have given Revive Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Revive Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Revive Therapeutics' next earnings date?

Revive Therapeutics is scheduled to release its next quarterly earnings announcement on Friday, February 26th 2021.
View our earnings forecast for Revive Therapeutics.

How were Revive Therapeutics' earnings last quarter?

Revive Therapeutics Ltd (CVE:RVV) announced its earnings results on Friday, November, 27th. The company reported ($0.02) earnings per share for the quarter.
View Revive Therapeutics' earnings history.

Who are some of Revive Therapeutics' key competitors?

Some companies that are related to Revive Therapeutics include Kane Biotech Inc. (KNE.V) (KNE), Devonian Health Group Inc. (GSD.V) (GSD), Realm Therapeutics (RLM), Nuformix plc (NFX.L) (NFX), Pascal Biosciences Inc. (PAS.V) (PAS), Naturally Splendid Enterprises Ltd. (NSP.V) (NSP), Medicure Inc. (MPH.V) (MPH), Bioasis Technologies Inc. (BTI.V) (BTI), Ovoca Bio plc (OVB.L) (OVB), Hemostemix Inc. (HEM.V) (HEM), Horizon Discovery Group plc (HZD.L) (HZD), Physiomics Plc (PYC.L) (PYC), iCo Therapeutics Inc. (ICO.V) (ICO), IBEX Technologies Inc. (IBT.V) (IBT) and Innovotech Inc. (IOT.V) (IOT).
View all of RVV's competitors.

What other stocks do shareholders of Revive Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Revive Therapeutics investors own include Heat Biologics (HTBX), The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGOD), Aurora Cannabis Inc. (ACB.TO) (ACB), CytoDyn (CYDY), Genprex (GNPX), iBio (IBIO), Sorrento Therapeutics (SRNE), Workhorse Group (WKHS), Acasti Pharma (ACST) and Anavex Life Sciences (AVXL).

Who are Revive Therapeutics' key executives?

Revive Therapeutics' management team includes the following people:
  • Mr. Craig Leon, Chairman & CEO (Age 51)
  • Mr. Fabio Chianelli, Pres & Director (Age 41)
  • Mr. Carmelo Marrelli C.A., C.P.A., CPA, B.Comm., CA, CGA, ACIS, Chief Financial Officer (Age 48)

What is Revive Therapeutics' stock symbol?

Revive Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RVV."

How do I buy shares of Revive Therapeutics?

Shares of RVV and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Revive Therapeutics' stock price today?

One share of RVV stock can currently be purchased for approximately C$0.08.

How big of a company is Revive Therapeutics?

Revive Therapeutics has a market capitalization of C$5.79 million.

What is Revive Therapeutics' official website?

The official website for Revive Therapeutics is www.revivethera.com.

How can I contact Revive Therapeutics?

Revive Therapeutics' mailing address is 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada. The company can be reached via phone at +1-905-6055535.

This page was last updated on 1/28/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.